News
IDEAYA Biosciences is well-capitalized, with a cash runway into 2029 and multiple upcoming catalysts. Click here to find out ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback